US-based gene therapy company Tocagen has agreed to provide exclusive rights for ApolloBio to develop and commercialise its drug candidate, Toca 511 & Toca FC, in the greater China region. The licensing agreement involves ApolloBio’s […]
Synpromics has partnered with Lonza Pharma & Biotech to further develop its inducible promoter system and enhance manufacturing of biopharmaceuticals. The 18-month project has been made possible through the award of a £235,000 grant, part […]
Germany-based Fresenius Kabi has scrapped its $4.3bn merger agreement with Akorn, saying that the US generic drugmaker did not fulfill various closing conditions. The German healthcare firm alleged that its independent investigation found material breaches […]
UK-based pharmaceutical company BenevolentAI has raised $115m to support its efforts to use artificial intelligence (AI) to develop drugs for hard-to-treat diseases. The funding round involved contribution from both new and existing investors, including Woodford […]
Pfenex Inc. (NYSE AMERICAN: PFNX) and China NT Pharma Group Company Limited (NT Pharma) (HKG:1011) today announced an agreement under which Pfenex granted NT Pharma non-exclusive development and exclusive commercialization rights to PF708, a teriparatide […]